Program
Please note that this meeting will take place as an in-person event in Philadelphia and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the REGISTRATION page for details.
All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program is subject to change.
Thursday, September 8
Friday, September 9
Plenary Session 1: Pathology
Plenary Session 2: Artificial Intelligence
Plenary Session 3: Controversies in Clinical Care (Debate Format)
Saturday, September 10
Plenary Session 4: What is the role of our current surgical treatments?
Plenary Session 5: Imaging
Plenary Session 6: Model Systems
Sunday, September 11
Plenary Session 7: Molecular Sequencing
Plenary Session 8: Microenvironment
Thursday, September 8
Welcome and Opening Lecture
6:45 p.m.-7:30 p.m.
Welcome from Cochairs
Opening Presentation
Angela M. Belcher, Massachusetts Institute of Technology, Cambridge, Massachusetts
Opening Reception
7:30 p.m.-10:00 p.m.
Friday, september 9
Breakfast
7-8 A.M.
Plenary Session 1: Pathology
Session Chair: Jorge S. Reis-Filho, Memorial Sloan Kettering Cancer Center, New York, New York
8-10 A.M.
Problems in the pathologic diagnosis of ductal carcinoma in situ
Stuart J. Schnitt, Dana-Farber Cancer Institute, Boston, Massachusetts
DCIS: Pathological heterogeneity and prognosis definition
Anne Vincent-Salomon, Institut Curie, Paris, France
Title to be announced
Jorge S. Reis-Filho
Short talks from proffered abstracts
Break
10–10:30 a.m.
Plenary Session 2: Artificial Intelligence
Session Chair: To be announced
10:30 a.m.–12:30 p.m.
Title to be announced
Andrew H. Beck, PathAI, Inc., Boston, Massachusetts
Title to be announced
Yinyin Yuan, Institute for Cancer Research, London, United Kingdom
Breast pathology and AI: Are we there yet?
Matthew G. Hanna, Memorial Sloan Kettering Cancer Center, New York, New York
Short talks from proffered abstracts
Poster Session A/ Lunch (provided)
12:30–2 p.m.
Plenary Session 3: Controversies in Clinical Care (debate format)
Moderator: To be announced
2:30–4:30 p.m.
Surgery should be done within weeks of diagnosis of DCIS
Jennifer L. Marti, Weill Cornell Medicine, New York, New York
Additional debater to be announced
Discussion
Radiation should be done for all women in the setting of breast conservation to reduce the risk invasive cancer
Bruce Mann, Royal Melbourne Hospital, Parkville, Australia
Additional debater to be announced
Discussion
Break/Dinner on own
4:30-7 P.M.
Workshops
7-8 P.M.
Human Tumor Atlas Network Workshop
Chair: Robert West, Stanford University, Stanford, California
Break
8-8:15 P.M.
Workshops
8:15-9:15 P.M.
PRECISION Workshop
Chair: Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands
Ductal carcinoma in situ: When cancer is not really cancer
Jelle Wesseling, Netherlands Cancer Institute, Amsterdam, The Netherlands
Friday September 9
Breakfast
7–8 A.M.
Plenary Session 4: What is the role of our current surgical treatments?
Session Chair: To be announced
8-10 A.M.
Title to be announced
Alistair Thompson, Dan L. Duncan Comprehensive Cancer Center, Houston, Texas
Title to be announced
Seema A. Khan, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
The evolving role of surgery as precision care for DCIS
E. Shelley Hwang, Duke Cancer Institute, Durham, North Carolina
Short talks selected from proffered abstracts
Break
10-10:30AM
Plenary Session 5: Imaging
Session Chair: To be announced
10:30 A.M.-12:30 P.M.
MR Imaging of active surveillance of DCIS – What we have learned so far
Heather Greenwood, UCSF, San Francisco, California
DCIS and MRI – Challenges and opportunities
Habib Rahbar, University of Washington School of Medicine, Seattle, Washington
Additional speaker to be announced
Short talks from proffered abstracts
Lunch on own
12:30-2:30 P.M.
Plenary Session 6: Model Systems
Session Chair: To be announced
2:30-4:45 P.M.
Title to be announced
Fariba Behbod, University of Kansas Medical Center, Kansas City, Kansas
Title to be announced
Senthil K. Muthuswamy, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Title to be announced
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, The Netherlands
Patient-derived organoids as models for breast cancer interception
Jennifer Rosenbluth, University of California, San Francisco, San Francisco, California
POSTER SESSION B / RECEPTION
4:45-7 P.M.
Sunday, September 11
Breakfast
7-8 A.M.
Plenary Session 7: Molecular Sequencing
Session Chair: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, Massachusetts
8-9:45 A.M.
Spatial heterogeneity in DCIS
Therese Sørlie, Oslo University Hospital, Oslo, Norway
Title to be announced
Nicholas E. Navin, UT MD Anderson Cancer Center, Houston, Texas
Additional speaker to be announced
Break
9:45-10:15 A.M.
Plenary Session 8: Microenvironment
Session Chair: Lisa Coussens, OHSU Knight Cancer Center, Portland, OR
10:15 A.M.-12 P.M.
Title to be announced
Alexander D. Borowsky, University of California-Davis, Davis, California
Myoepithelial cell differentiation as a harbinger of DCIS progression and potential target for prevention
Pepper Schedin OHSU, Portland, Oregon
Title to be announced
Kornelia Polyak Dana-Farber Cancer Institute, Boston, Massachusetts